Early onset neutropenia after rituximab in lupus nephritis.
Enríquez
R
R
Borrás-Blasco
J
J
Sirvent
A E
AE
Masía
M
M
Amorós
F
F
D017668:Age of Onset; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002452:Cell Count; D005260:Female; D006801:Humans; D008181:Lupus Nephritis / Q000188:drug therapy*; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced* / Q000473:pathology; D009504:Neutrophils / Q000473:pathology; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab